| Previous Section | Index | Home Page |
12 Jan 2006 : Column 759W—continued
Light Rail
Mr. Duncan: To ask the Secretary of State for Transport how much was given in subsidy by his Department to each light rail scheme currently in operation in each year since they commenced operation. [27504]
Mr. Darling [holding answer 11 November 2005]: The following light rail schemes are currently in operation in England.
Of these, only the Docklands Light Railway (DLR) and the Tyne and Wear Metro, have received operating subsidy from the Department for Transport or its predecessors and agencies.
The operating subsidy provided is as follows.
From 2000 the DLR subsidy has been paid by Transport for London (TfL).
For the years prior to 1996–97 it is not possible to separately identify the Metro element within the overall support provided for heavy rail and Metro services in Tyne and Wear.
The concessionaire of Croydon Tramlink, though it does not receive a revenue subsidy from central Government, is entitled to compensation on a 'no better, no worse' basis where fares policy enacted by the
12 Jan 2006 : Column 760W
Mayor results in revenues per trip falling below those assumed in the 1996 financing plan which underpinned the Private Finance Initiative concession. It received compensation payments of £5.501 million in 2003–04 and £5.812 million (estimated) in 2004–05.
The local authorities which are responsible for the running of these systems may make some contribution to their operating costs depending on the commercial arrangements with the system operators in each particular case. The Department does not hold any central records on this.
The Department's capital expenditure on the construction of light rail systems in England since 1980 is as follows:
| Amount | |
|---|---|
| Tyne and Wear Metro | 237.5 |
| Docklands Light Railway | 335.5 |
| Manchester Metrolink | 123.0 |
| Sheffield Supertram | 220.0 |
| Midland Metro | 80.0 |
| Croydon Tramlink | 125.0 |
| Nottingham Express Transit | 167.0 |
Normally this is paid as an upfront capital sum, except in the case of Nottingham Express Transit where the funding is in the form of annual availability payments.
Mobility and Inclusion Unit
Danny Alexander: To ask the Secretary of State for Transport if he will list the work completed to date by the Mobility and Inclusion Unit; and what issues the unit is working on. [40743]
Ms Buck: The Mobility and Inclusion Unit contributes to the delivery of the Department for Transport's aim to
make transport accessible and affordable to users of public transport, pedestrians and motorists, and to promote diversity in transport provision".
Specifically the current focus of the unit is to:
improve accessibility to transport, in particular through implementation of Disability Discrimination Act 1995 and 2005 provisions, and promote personal mobility;
reduce social exclusion through implementation of recommendations of the Social Exclusion Unit report and promote social inclusion, in particular through implementation of the Race Equality Scheme;
Details of the recent achievements and current objectives of the unit can be found in the Mobility and Inclusion Unit Business Plan 2005–06 which is available on the Department for Transport's website.
Danny Alexander: To ask the Secretary of State for Transport what his policy is on the retention of expertise in the Mobility and Inclusion Unit; and if he will make a statement. [40744]
12 Jan 2006 : Column 761W
Ms Buck: Staff in the Mobility and Inclusion Unit often stay in posts longer than is usual elsewhere in the Department for Transport. We balance the benefits of retaining expertise in the short-term with providing opportunities for development and promotion to allow us to sustain this valuable work in the long-term.
Passenger Subsidies
Mr. Andrew Turner: To ask the Secretary of State for Transport what the (a) capital and (b) revenue subsidy per passenger mile travelled was for each transport authority in the most recent year for which figures are available. [38159]
Ms Buck [holding answer 19 December 2005]: I refer the hon. Member to my answer of 12 December 2005, Official Report, column 1620W.
Public Service Agreements
Mr. Amess: To ask the Secretary of State for Transport if he will make a statement on progress of each public service agreement target set for his Department. [40980]
Ms Buck:
Progress against public service agreement targets is set out in the Department's annual report and autumn performance report, as well as on the Department's website.
12 Jan 2006 : Column 762W
Mr. Amess: To ask the Secretary of State for Transport what discussions he has had with stakeholders about progress of each public service agreement target set for his Department; and if he will make a statement. [40981]
Ms Buck: Management of public service agreement targets is an integral part of the Department's business and discussions with stakeholders about delivery of these targets take place on a routine basis.
TREASURY
Cancer
Mr. Baron: To ask the Chancellor of the Exchequer how many people were diagnosed with (a) prostate cancer, (b) breast cancer, (c) bowel cancer, (d) lung cancer and (e) all other cancers in each of the last 10 years. [41166]
John Healey: The information requested falls within the responsibility of the National Statistician, who has been asked to reply.
Letter from Karen Dunnell, dated 12 January 2006:
As National Statistician, I have been asked to reply to your recent question concerning how many people were diagnosed with (a) prostate cancer, (b) breast cancer, (c) bowel cancer, (d) lung cancer and (e) all other cancers in each of the last 10 years.(41166)
The most recent available information on registration of newly diagnosed cases (incidence) is for the year 2003. Numbers of newly diagnosed cases of selected cancers registered in England and Wales between 1994 and 2003 are given in the attached table.
(1)Cancers registered in 1994 and 1995–2003 are, respectively, defined by codes in the International Classification of Diseases, Ninth Revision (IC.D9) and Tenth Revision (JCDI0). Therefore, prostate cancer is defined by codes 185 or C61, breast cancer by codes 174 or C50, colorectal (bowel) cancer by codes 153–154 or C18-C21 and lung cancer by codes 162 or C33-C34.
(2)All other cancers" are defined by codes 140–208 or COO-C97 (excluding non-melanoma skin cancer 173 or C44 and excluding the codes in footnote 1 above).
Source:
Office for National Statistics
Mr. Baron: To ask the Chancellor of the Exchequer how many people died from (a) prostate cancer, (b) breast cancer, (c) bowel cancer, (d) lung cancer and (e) all other cancers in each of the last 10 years. [41167]
John Healey: The information requested falls within the responsibility of the National Statistician who has been asked to reply.
Letter from Karen Dunnell, dated 12 January 2006:
As National Statistician I have been asked to reply to your recent question asking how many people died from (a) prostate cancer, (b) breast cancer, (c) bowel cancer, (d) lung cancer and (e) all other cancers in each of the last 10 years. (41167)
The latest year for which data are available is 2004. Figures for deaths from cancer by site are shown in the attached table for each year from 1995 to 2004.
(3)The cause of death was defined using the International Classification of Diseases, Ninth Revision (ICD-9) for the years 1995 to 2000, and the International Classification of Diseases, Tenth Revision (ICD-10) for 2001 onwards. The codes used are listed as follows:
Malignant neoplasm of prostate—ICD-9 185; ICD-10 C61;
Malignant neoplasm of breast—ICD-9 174–175; ICD-10 C50;
Malignant neoplasm of colon and rectum—ICD-9 153/154; ICD-10 C18-C21;
Malignant neoplasm of trachea, bronchus and lung—ICD-9 162; ICD-10 C33-C34;
Other cancer sites—ICD-9 140–208 excluding the above codes; ICD-10 C00-C97 excluding the above codes.
(4)Figures are based on deaths occurring in each calendar year.
(5)Figures include deaths in males as well as females.
(6)The introduction of ICD-10 for coding cause of death in 2001 means that data for cancer are not completely comparable with data for years before this date. The data should therefore be interpreted with caution. The effect of the change in classification in 2001 on deaths from cancer by site is described in an article published in August 2004 (7) .
(8)Brock A. Griffiths C. Rooney C (2004) The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales. Health Statistics Quarterly 23. 7–17.
12 Jan 2006 : Column 763W
Mr. Baron: To ask the Chancellor of the Exchequer what the five-year survival rates were for (a) prostate cancer, (b) breast cancer, (c) bowel cancer, (d) lung cancer and (e) all other cancers in each of the last 10 years. [41168]
John Healey: The information requested falls within the responsibility of the National Statistician, who has been asked to reply.
Letter from Karen Dunnell, dated 12 January 2006:
As National Statistician, I have been asked to reply to your recent question concerning what the five-year survival rates were for (a) prostate cancer, (b) breast cancer, (c) bowel cancer, (d) lung cancer and (e) all other cancers in each of the last 10 years.(41168)
Cancer survival rates are only produced for specific cancers and are calculated by combining several years of diagnosis.
The latest available five-year survival rates for the selected major cancers in England are for adult patients (aged 15–99 years) diagnosed during 1998–2001 and followed up to the end of 2003, These figures and survival rates for patients diagnosed during 1991–95 and 1996–99 in England and Wales are given in the attached table.
12 Jan 2006 : Column 764W
(9)As cancer survival varies with age at diagnosis, the relative rates for all ages (15–99) have been age-standardised to control for changes in the age profile of cancer patients over time, thus making them comparable with previously published figures.
(10)Aged 15–99 years.
(11)Cancers registered in 1991–94 and 1995–2001 are, respectively, defined by codes in the International Classification of Diseases, Ninth Revision (ICD9) and Tenth Revision ICD10). Therefore, prostate cancer is defined by codes 185 or C61, breast cancer by codes 174 or C50, colorectal (bowel) cancer by codes 153–154 or C18-C21 and lung cancer by codes 162 or C33-C34.
Source:
Office for National Statistics
Mr. Baron: To ask the Chancellor of the Exchequer what the mortality rate was for cancer in people under 75 years in each of the last 10 years. [41169]
John Healey: The information requested falls within the responsibility of the National Statistician who has been asked to reply.
Letter from Karen Dunnell, dated 12 January 2006:
As National Statistician I have been asked to reply to your recent question asking what the mortality rate was for cancer in people under 75 years in each of the last 10 years. (41169)
The latest year for which data are available is 2004. Figures for deaths from cancer in people aged under 75 years are shown in the attached table for each year from 1995 to 2004.
(12)Age-standardised to the European standard population.
(13)The cause of death was defined using the International Classification of Diseases, Ninth Revision (ICD-9) for the years 1995 to 2000, and the International Classification of Diseases, Tenth Revision (ICD-10) for 2001 onwards. The codes used are listed as follows:
Malignant neoplasms—ICD-9 140–208; ICD-10 C00 C97.
(14)Data exclude deaths at age under 28 days.
(15)Figures are based on deaths occurring in each calendar year.
(16)The introduction of ICD-10 for coding cause of death in 2001 means that data for cancer are not completely comparable with data for years before this date. The figures presented in this table for the years 1993 to 2000 have been adjusted using comparability ratios to be comparable with ICD-10.
The effect of the change in classification in 2001 on deaths from all cancer and cancer by site is described in an article published in August 2004.*
*Brock A, Griffiths C, Rooney C (2004) The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales Health Statistics Quarterly" 23, 7–17.
12 Jan 2006 : Column 765W
| Next Section | Index | Home Page |